Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.
Academic Centre of Specialists, Department of Rheumatology, Stockholm, Sweden.
Kidney Int. 2023 May;103(5):973-985. doi: 10.1016/j.kint.2023.01.023. Epub 2023 Feb 15.
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease involving autoreactivity to proteinase 3 (PR3) as demonstrated by presence of ANCAs. While autoantibodies are screened for diagnosis, autoreactive T cells and their features are less well-studied. Here, we investigated PR3-specific CD4+T cell responses and features of autoreactive T cells in patients with PR3-AAV, using a cohort of 72 patients with either active or inactive disease. Autoreactive PR3-specific CD4+T cells producing interferon γ in response to protein stimulation were found to express the G-protein coupled receptor 56 (GPR56), a cell surface marker that distinguishes T cells with cytotoxic capacity. GPR56+CD4+T cells were significantly more prominent in the blood of patients with inactive as compared to active disease, suggesting that these cells were affected by immunosuppression and/or that they migrated from the circulation to sites of organ involvement. Indeed, GPR56+CD4+T cells were identified in T-cell infiltrates of affected kidneys and an association with immunosuppressive therapy was found. Moreover, distinct TCR gene segment usage and shared (public) T cell clones were found for the PR3-reactive TCRs. Shared T cell clones were found in different patients with AAV carrying the disease-associated HLA-DP allele, demonstrating convergence of the autoreactive T cell repertoire. Thus, we identified a CD4+T cell signature in blood and in affected kidneys that display PR3 autoreactivity and associates with T cell cytotoxicity. Our data provide a basis for novel rationales for both immune monitoring and future therapeutic intervention in PR3-AAV.
抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)是一种自身免疫性疾病,涉及到对蛋白酶 3(PR3)的自身反应性,这一点通过存在 ANCAs 得到证实。虽然自身抗体用于诊断,但自身反应性 T 细胞及其特征研究得较少。在这里,我们使用一组 72 例活动性或非活动性疾病患者,研究了 PR3-AAV 患者中 PR3 特异性 CD4+T 细胞反应和自身反应性 T 细胞的特征。发现对蛋白刺激产生干扰素 γ的 PR3 特异性 CD4+T 细胞表达 G 蛋白偶联受体 56(GPR56),这是一种区分具有细胞毒性能力的 T 细胞的细胞表面标记。与活动性疾病相比,非活动性疾病患者的血液中 GPR56+CD4+T 细胞更为明显,这表明这些细胞受到免疫抑制的影响和/或它们从循环迁移到器官受累部位。事实上,在受影响的肾脏的 T 细胞浸润中鉴定出 GPR56+CD4+T 细胞,并发现与免疫抑制治疗有关。此外,还发现了用于 PR3 反应性 TCR 的不同 TCR 基因片段使用和共享(公共)T 细胞克隆。在携带疾病相关 HLA-DP 等位基因的不同 AAV 患者中发现了共享的 T 细胞克隆,证明了自身反应性 T 细胞库的收敛。因此,我们在血液和受影响的肾脏中鉴定出了一种显示 PR3 自身反应性并与 T 细胞细胞毒性相关的 CD4+T 细胞特征。我们的数据为 PR3-AAV 的免疫监测和未来治疗干预提供了新的依据。